Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Sep 14, 2014; 20(34): 12171-12181
Published online Sep 14, 2014. doi: 10.3748/wjg.v20.i34.12171
Published online Sep 14, 2014. doi: 10.3748/wjg.v20.i34.12171
Figure 4 Effects of glycosylation inhibitors on Panc-1 and Capan-1 cell adhesion.
Microscopic images of A-C: Panc-1; or D-F: Capan-1 cells adhered to. A, D: Controls; B, E: 48 h treatment with 2.0 mg% tunicamycin; C, F: 48 h treatment with 5.0 mmol/L benzyl-N-acetyl-α-galactosaminide; G, H: Average adhered cell numbers; aP < 0.05 vs controls; cP < 0.05 vs benzyl-N-acetyl-α-galactosaminide.
- Citation: Xu HL, Zhao X, Zhang KM, Tang W, Kokudo N. Inhibition of KL-6/MUC1 glycosylation limits aggressive progression of pancreatic cancer. World J Gastroenterol 2014; 20(34): 12171-12181
- URL: https://www.wjgnet.com/1007-9327/full/v20/i34/12171.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i34.12171